2,033
Views
16
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

High incidence of fistula formation during bevacizumab treatment in rectal cancer patients

, , , &
Pages 550-553 | Received 23 Aug 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jair Bar & Amir Onn. (2008) Combined anti-proliferative and anti-angiogenic strategies for cancer. Expert Opinion on Pharmacotherapy 9:5, pages 701-715.
Read now

Articles from other publishers (15)

T. O’Hare, R. McDermott & R. Hannon. (2017) Late anastomotic breakdown with bevacizumab in colorectal cancers, a case-based review. Irish Journal of Medical Science (1971 -) 187:2, pages 333-336.
Crossref
Marinos C. Makris, Michael Kornaropoulos, Apostolos Krikelis, Demetrios Moris, Diamantis I. Tsilimigras, Elia Modestou, Artemis Liapi, Vasileios Karatzias, Christos Damaskos & Andreas Zevlas. (2018) Use of a biological mesh for the treatment of perineal fistula following radical colorectal resection. Clinical Case Reports 6:5, pages 926-929.
Crossref
C. Hayashi, S. Takada, A. Kasuga, K. Shinya, M. Watanabe, H. Kano & T. Takayama. (2016) Sigmoid-vaginal fistula during bevacizumab treatment diagnosed by fistulography. Journal of Clinical Pharmacy and Therapeutics 41:6, pages 725-726.
Crossref
Mariko FURUKORI, Yasuhiro YAMAMOTO, Mikio OKAMURA, Kengo SHIGEHARA & Aki YAGI. (2014) Three Cases of Anal Fistula during Bevacizumab-containing Chemotherapy for Colorectal Cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 75:9, pages 2374-2381.
Crossref
Elisabeth Chéreau, Eric Lambaudie & Gilles Houvenaeghel. (2013) Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer. International Journal of Gynecologic Cancer 23:7, pages 1326-1330.
Crossref
Samuel E. Borofsky, Marc S. Levine, Stephen E. Rubesin, Janos L. Tanyi, Christina S. Chu & Anna S. Lev-Toaff. (2012) Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients. Abdominal Imaging 38:2, pages 265-272.
Crossref
Jalid Sehouli, G. Papanikolaou, E.-I. Braicu, K. Pietzner, P. Neuhaus & C. Fotopoulou. (2011) Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer. Annals of Surgical Oncology 19:4, pages 1326-1333.
Crossref
Asvin M. Ganapathi, Tammy Westmoreland, Douglas Tyler & Christopher R. Mantyh. (2012) Bevacizumab-Associated Fistula Formation in Postoperative Colorectal Cancer Patients. Journal of the American College of Surgeons 214:4, pages 582-588.
Crossref
Clarisse Eveno, Christine le Maignan, Philippe Soyer, Marine Camus, Emmanuel Barranger & Marc Pocard. (2011) Late anastomotic colonic dehiscence due to antiangiogenic treatment, a specific drug-class complication requiring specific treatment: An example of pazopanib complication. Clinics and Research in Hepatology and Gastroenterology 35:2, pages 135-139.
Crossref
Carlos Placer, Izaskun Markinez, Araceli Rodríguez, Jose Luis Elósegui & Jose María Enríquez Navascués. (2010) Dehiscencia anastomótica tardía en cáncer colorrectal avanzado tratado con Bevacizumab™. Cirugía Española 88:4, pages 267-268.
Crossref
Helen J. Mackay, Anna Tinker, Eric Winquist, Gillian Thomas, Kenneth Swenerton, Amit Oza, Joana Sederias, Percy Ivy & Elizabeth A. Eisenhauer. (2010) A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184. Gynecologic Oncology 116:2, pages 163-167.
Crossref
Judith Meza-Junco, Clarence Wong, Anthony Fields & Michael B. Sawyer. (2009) Esophageal ulcer in a patient who received bevacizumab. Investigational New Drugs 28:1, pages 98-101.
Crossref
Thierry Bège, Bernard Lelong, Frederic Viret, Olivier Turrini, Jerome Guiramand, Delphine Topart, Laurence Moureau-Zabotto, Marc Giovannini, Anthony Gonçalves & Jean Robert Delpero. (2009) Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients. Annals of Surgical Oncology 16:4, pages 856-860.
Crossref
Elisabeth Chéreau, Dan Stefanescu, Frédéric Selle, Roman Rouzier & Emile Daraï. (2009) Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report. American Journal of Obstetrics and Gynecology 200:1, pages e15-e16.
Crossref
Jair Bar, Roy S. Herbst & Amir Onn. (2008) Multitargeted Inhibitors in Lung Cancer: New Clinical Data. Clinical Lung Cancer 9, pages S92-S99.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.